114 related articles for article (PubMed ID: 16980889)
1. Green tea polyphenol extract attenuates zymosan-induced non-septic shock in mice.
Di Paola R; Mazzon E; Muià C; Crisafulli C; Genovese T; Di Bella P; Esposito E; Menegazzi M; Meli R; Suzuki H; Cuzzocrea S
Shock; 2006 Oct; 26(4):402-9. PubMed ID: 16980889
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Fulia F; Cuzzocrea E; Di Rosa M; Caputi AP; Thiemermann C
Crit Care Med; 2004 Feb; 32(2):457-66. PubMed ID: 14758164
[TBL] [Abstract][Full Text] [Related]
3. Ethyl pyruvate reduces the development of zymosan-induced generalized inflammation in mice.
Di Paola R; Mazzon E; Genovese T; Crisafulli C; Bramanti P; Caminiti R; Esposito E; Fink MP; Cuzzocrea S
Crit Care Med; 2009 Jan; 37(1):270-82. PubMed ID: 19050619
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice.
Cuzzocrea S; Di Paola R; Mazzon E; Patel NS; Genovese T; Muià C; Crisafulli C; Caputi AP; Thiemermann C
Crit Care Med; 2006 Apr; 34(4):1168-77. PubMed ID: 16484922
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of M40401, a selective superoxide dismutase mimetic, on zymosan-induced nonseptic shock.
Cuzzocrea S; Mazzon E; Di Paola R; Genovese T; Serraino I; Dugo L; Cuzzocrea E; Fulia F; Caputi AP; Salvemini D
Crit Care Med; 2004 Jan; 32(1):157-67. PubMed ID: 14707575
[TBL] [Abstract][Full Text] [Related]
6. Hypericum perforatum attenuates the development of cerulein-induced acute pancreatitis in mice.
Genovese T; Mazzon E; Di Paola R; Muià C; Crisafulli C; Menegazzi M; Malleo G; Suzuki H; Cuzzocrea S
Shock; 2006 Feb; 25(2):161-7. PubMed ID: 16525355
[TBL] [Abstract][Full Text] [Related]
7. The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat.
Dugo L; Chatterjee PK; Mazzon E; McDonald MC; Paola RD; Fulia F; Caputi AP; Thiemermann C; Cuzzocrea S
Intensive Care Med; 2002 Jun; 28(6):775-88. PubMed ID: 12107686
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of Hypericum perforatum in zymosan-induced multiple organ dysfunction syndrome: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity.
Di Paola R; Mazzon E; Muià C; Crisafulli C; Genovese T; Di Bella P; Esposito E; Menegazzi M; Meli R; Suzuki H; Cuzzocrea S
Nitric Oxide; 2007 Feb; 16(1):118-30. PubMed ID: 16889996
[TBL] [Abstract][Full Text] [Related]
9. Glutamine treatment attenuates the development of organ injury induced by zymosan administration in mice.
Mondello S; Galuppo M; Mazzon E; Italiano D; Mondello P; Aloisi C; Cuzzocrea S
Eur J Pharmacol; 2011 May; 658(1):28-40. PubMed ID: 21349270
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase 3beta inhibition reduces the development of nonseptic shock induced by zymosan in mice.
Cuzzocrea S; Di Paola R; Mazzon E; Crisafulli C; Genovese T; Muià C; Abdelrahman M; Esposito E; Thiemermann C
Shock; 2007 Jan; 27(1):97-107. PubMed ID: 17172987
[TBL] [Abstract][Full Text] [Related]
11. PD98059, a specific MAP kinase inhibitor, attenuates multiple organ dysfunction syndrome/failure (MODS) induced by zymosan in mice.
Di Paola R; Galuppo M; Mazzon E; Paterniti I; Bramanti P; Cuzzocrea S
Pharmacol Res; 2010 Feb; 61(2):175-87. PubMed ID: 19819333
[TBL] [Abstract][Full Text] [Related]
12. Role of interleukin-6 in a non-septic shock model induced by zymosan.
Cuzzocrea S; de Sarro G; Costantino G; Mazzon E; Laurà R; Ciriaco E; de Sarro A; Caputi AP
Eur Cytokine Netw; 1999 Jun; 10(2):191-203. PubMed ID: 10400825
[TBL] [Abstract][Full Text] [Related]
13. Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in mice.
Cuzzocrea S; Rossi A; Pisano B; Di Paola R; Genovese T; Patel NS; Cuzzocrea E; Ianaro A; Sautebin L; Fulia F; Chatterjee PK; Caputi AP; Thiemermann C
Intensive Care Med; 2003 Nov; 29(11):2016-25. PubMed ID: 12879239
[TBL] [Abstract][Full Text] [Related]
14. Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan.
Di Paola R; Esposito E; Mazzon E; Genovese T; Muià C; Crisafulli C; Malleo G; Sessa E; Meli R; Cuzzocrea S
Shock; 2006 Nov; 26(5):477-84. PubMed ID: 17047518
[TBL] [Abstract][Full Text] [Related]
15. Olprinone, a specific phosphodiesterase (PDE)-III inhibitor, reduces the development of multiple organ dysfunction syndrome in mice.
Mazzon E; Esposito E; Di Paola R; Impellizzeri D; Bramanti P; Cuzzocrea S
Pharmacol Res; 2011 Jul; 64(1):68-79. PubMed ID: 21193041
[TBL] [Abstract][Full Text] [Related]
16. Fumonisin b1 reduces the development of multiple organ failure induced by zymosan in mice.
Cuzzocrea S; Genovese T; Mazzon E; Esposito E; Crisafulli C; Di Paola R; Bramanti P; Salvemini D
Shock; 2009 Feb; 31(2):170-7. PubMed ID: 18650782
[TBL] [Abstract][Full Text] [Related]
17. Etanercept reduces acute tissue injury and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
Malleo G; Mazzon E; Genovese T; Di Paola R; Muià C; Caminiti R; Esposito E; Di Bella P; Cuzzocrea S
Shock; 2008 May; 29(5):560-71. PubMed ID: 17724436
[TBL] [Abstract][Full Text] [Related]
18. Effect of NADPH-oxidase inhibitors in the experimental model of zymosan-induced shock in mice.
Impellizzeri D; Mazzon E; Di Paola R; Paterniti I; Bramanti P; Cuzzocrea S
Free Radic Res; 2011 Jul; 45(7):820-34. PubMed ID: 21623687
[TBL] [Abstract][Full Text] [Related]
19. Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan.
Cuzzocrea S; Mazzon E; Dugo L; Barbera A; Centorrino T; Ciccolo A; Fonti MT; Caputi AP
Shock; 2001 Jul; 16(1):51-8. PubMed ID: 11442316
[TBL] [Abstract][Full Text] [Related]
20. Methylguanidine reduces the development of non septic shock induced by zymosan in mice.
Marzocco S; Di Paola R; Genovese T; Sorrentino R; Britti D; Scollo G; Pinto A; Cuzzocrea S; Autore G
Life Sci; 2004 Aug; 75(12):1417-33. PubMed ID: 15240178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
